Literature DB >> 17096074

The lack of genetic association of the Toll-like receptor 2 (TLR2) Arg753Gln and Arg677Trp polymorphisms with rheumatic heart disease.

Nurşen Düzgün1, Türker Duman, Filiz Ekşi Haydardedeoğlu, Hüseyin Tutkak.   

Abstract

UNLABELLED: Acute rheumatic fever (ARF) is a non-suppurative inflammatory disease after group A, beta haemolytic streptococcal pharyngitis. Certain individuals can develop ARF. This finding implies variability in host predisposition to ARF. A variety of studies have linked specific genetic markers with ARF or rheumatic heart disease (RHD) as a sequelae of ARF. For this purpose, we aimed to search the role of polymorphisms in Toll-like receptor-2 and -4 (TLR2 and TLR4) gene in Turkish patients with RHD. This study included a total 84 patients with RHD, ages ranging between 18 and 65, 25 male and 59 female, fulfilling the revised classification criteria of Jones. One hundred forty healthy unrelated persons were selected as a control group. Genotype analysis: DNA was extracted from whole blood. TLR4 gene (Asp 299Gly and Thr399Ile) and TLR2 gene (Arg753Gln and Arg677Trp) polymorphisms were genotyped by the previously reported method. STATISTICAL ANALYSIS: binary logistic regression models were used. Results were expressed as odds ratios (OR) with corresponding 95% confidence intervals (95% CI). Significant level was predefined at 0.05. There was a significant difference for carrying Ile allele in the 399 position in the patients compared to healthy controls (OR = 5.26, 95% CI, 1.40-19.73, p = 0.014). In the TLR4 gene, Asp 299Gly polymorphism did not reach to a statistically significant value (OR = 3.02). We found no Arg753Gln polymorphism of the TLR2 gene in the patient group. There were three heterozygote samples in the healthy group. We did not detect Arg677Trp polymorphism of the TLR2 gene in both patient and control groups.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17096074     DOI: 10.1007/s10067-006-0432-x

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN: 0770-3198            Impact factor:   3.650


  29 in total

Review 1.  Toll-like receptors and innate immunity.

Authors:  R Medzhitov
Journal:  Nat Rev Immunol       Date:  2001-11       Impact factor: 53.106

2.  TLR4 mutations are associated with endotoxin hyporesponsiveness in humans.

Authors:  N C Arbour; E Lorenz; B C Schutte; J Zabner; J N Kline; M Jones; K Frees; J L Watt; D A Schwartz
Journal:  Nat Genet       Date:  2000-06       Impact factor: 38.330

3.  TLR-2 gene Arg753Gln polymorphism is strongly associated with acute rheumatic fever in children.

Authors:  Afig Berdeli; Handan Ak Celik; Ruhi Ozyürek; Buket Dogrusoz; Hikmet Hakan Aydin
Journal:  J Mol Med (Berl)       Date:  2005-06-21       Impact factor: 4.599

4.  Innate immunity and arthritis: neutrophil Rac and toll-like receptor 4 expression define outcomes in infection-triggered arthritis.

Authors:  Xiang Zhang; Michael Glogauer; Fei Zhu; Tae-Hwan Kim; Basil Chiu; Robert D Inman
Journal:  Arthritis Rheum       Date:  2005-04

5.  Endocytosed HSP60s use toll-like receptor 2 (TLR2) and TLR4 to activate the toll/interleukin-1 receptor signaling pathway in innate immune cells.

Authors:  R M Vabulas; P Ahmad-Nejad; C da Costa; T Miethke; C J Kirschning; H Häcker; H Wagner
Journal:  J Biol Chem       Date:  2001-06-11       Impact factor: 5.157

6.  Lack of genetic association of the Toll-like receptor 4 (TLR4) Asp299Gly and Thr399Ile polymorphisms with spondylarthropathies in a Hungarian population.

Authors:  P Gergely; A Blazsek; Z Weiszhár; B Pazár; G Poór
Journal:  Rheumatology (Oxford)       Date:  2006-03-27       Impact factor: 7.580

Review 7.  Interactions of fibronectin with streptococci: the role of fibronectin as a receptor for Streptococcus pyogenes.

Authors:  W A Simpson; H S Courtney; I Ofek
Journal:  Rev Infect Dis       Date:  1987 Jul-Aug

8.  Assay of locus-specific genetic load implicates rare Toll-like receptor 4 mutations in meningococcal susceptibility.

Authors:  Irina Smirnova; Navjiwan Mann; Annemiek Dols; H H Derkx; Martin L Hibberd; Michael Levin; Bruce Beutler
Journal:  Proc Natl Acad Sci U S A       Date:  2003-05-02       Impact factor: 11.205

Review 9.  Innate immunity and toll-like receptors: clinical implications of basic science research.

Authors:  Maria T Abreu; Moshe Arditi
Journal:  J Pediatr       Date:  2004-04       Impact factor: 4.406

Review 10.  Toll-like receptors.

Authors:  Kiyoshi Takeda; Tsuneyasu Kaisho; Shizuo Akira
Journal:  Annu Rev Immunol       Date:  2001-12-19       Impact factor: 28.527

View more
  5 in total

1.  Different patterns of Toll-like receptor 2 polymorphisms in populations of various ethnic and geographic origins.

Authors:  M Ioana; B Ferwerda; T S Plantinga; M Stappers; M Oosting; M McCall; A Cimpoeru; F Burada; N Panduru; R Sauerwein; O Doumbo; J W M van der Meer; R van Crevel; L A B Joosten; M G Netea
Journal:  Infect Immun       Date:  2012-02-21       Impact factor: 3.441

Review 2.  Association of TLR1, TLR2, TLR4, TLR6, and TIRAP polymorphisms with disease susceptibility.

Authors:  Mamoona Noreen; Muhammad Arshad
Journal:  Immunol Res       Date:  2015-06       Impact factor: 2.829

3.  No association of the TLR2 gene Arg753Gln polymorphism with rheumatic heart disease and Behçet's disease.

Authors:  Fulya Coşan; Başar Oku; Aris Cakiris; Julide Duymaz-Tozkir; Fehmi Mercanoğlu; Güher Saruhan-Direskeneli; Duran Ustek; Ahmet Gül
Journal:  Clin Rheumatol       Date:  2009-08-21       Impact factor: 2.980

4.  Angiotensin converting enzyme DD genotype is associated with development of rheumatic heart disease in Egyptian children.

Authors:  Mohamed-Mofeed Fawaz Morsy; Nada Abdelmohsen Mohamed Abdelaziz; Ahmed Mohamed Boghdady; Hydi Ahmed; Essam Mohamed Abu Elfadl; Mohamed Ali Ismail
Journal:  Rheumatol Int       Date:  2009-10-22       Impact factor: 2.631

Review 5.  Relevance of single-nucleotide polymorphisms in human TLR genes to infectious and inflammatory diseases and cancer.

Authors:  A Trejo-de la O; P Hernández-Sancén; C Maldonado-Bernal
Journal:  Genes Immun       Date:  2014-03-13       Impact factor: 2.676

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.